Conference Chairman
Roger Kamm
Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT) |
 Keynote Speakers
Peter Ertl
Professor of Lab-on-a-Chip Systems, Vienna University of Technology | 
Albert Folch
Professor of Bioengineering, University of Washington | 
James Hickman
Professor, Nanoscience Technology, Chemistry, Biomolecular Science and Electrical Engineering, University of Central Florida; Chief Scientist, Hesperos |
Roger Kamm
Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT) | 
Shay Soker
Professor of Regenerative Medicine and Chief Science Program Officer, Wake Forest Institute for Regenerative Medicine |
OverviewWelcome to the SelectBIO 2D-to-3D Culture and Organoids 2020 Conference to be held August 19-20, 2020 in Boston. This
conference brings together the innovations in 3D-Culture and Organoids, circa 2020
and bring the key opinion leaders and thought leaders in the field from
around the world for two intensive days of scientific presentations,
networking as well as engagement with companies developing innovations
in tools and technologies in this expanding space. This conference was originally scheduled for March 25-26, 2020 in Boston but rescheduled due to the worldwide Coronavirus situation. All registrations, sponsors and exhibitors for the March 2020 meeting have been automatically rolled-over to this meeting.
All visitors entering Massachusetts, including returning residents, who do not meet an exemption, are required to:
Complete
the Massachusetts Travel Form prior to arrival, unless you are visiting
from a lower-risk state (VT, NH, ME, CT, NY, NJ, HI)
Quarantine
for 14 days or produce a negative COVID-19 test result that has been
administered up to 72-hours prior to your arrival in Massachusetts.
If
your COVID-19 test result has not been received prior to arrival,
visitors, and residents must quarantine until they receive a negative
test result.
Failure to comply may result in a $500 fine per day. Please kindly follow the government guidelines carefully.
 SelectBIO Conference Safety Guidelines Relating to COVID-19
Agenda Topics- 3D Culture to Organoid to Organ-on-a-Chip Continuum
- Case Studies using Organoids in Research, High Throughput Screening and Personalized Medicine
- Converting from 2D to 3D Culture Models
- Development and use of Advanced Microfluidic Chip Devices for Studying Organoids
- Emerging Technologies for Reproducible Production of Organoids
- High Content Imaging and Phenotypic Assays of 3D Culture Models
- Organoid Models for Studying Infectious Diseases
- Organoids-on-a-Chip
- Spheroids -- 3D Aggregates of Cells in Culture
- Tumor Organoids
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865
|
Distinguished FacultyRené Overmeer, Assay Development & Screening Manager, Hubrecht Organoid Technology (HUB)
Ryuji Morizane, Assistant Professor, Harvard Medical School; Visiting Scholar, Wyss Institute
Jeffrey Borenstein, Group Leader, Synthetic Biology; Director, Biomedical Engineering Center, Draper
Jennifer Rosenbluth, Instructor in Medicine, Dana-Farber Cancer Institute
Milos Kostic, Researcher, Novartis Institutes for BioMedical Research
Qin Wang, Scientist, Drug Safety Research & Evaluation, Takeda Pharmaceuticals, Inc.
Terry Riss, Senior Product Manager, Cell Health, Promega Corporation
Matthias von Herrath, Vice President and Senior Medical Officer, Novo Nordisk, Professor, La Jolla Institute
|
| Corporate Sponsors | Web Sponsors | Offical Journal Partner | Networking |
| |  |  |
|
